RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65

TerminatedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

February 13, 2024

Study Completion Date

February 13, 2024

Conditions
Aortic Valve Replacement
Interventions
DIAGNOSTIC_TEST

Subjects previously implanted with a RESILIA aortic tissue valve.

Subjects to undergo multi-slice computed tomography and echocardiogram to assess predictors of valve durability in previously implanted Edwards aortic valves with RESILIA tissue.

Trial Locations (10)

10032

Columbia University Medical Center-NY Presbyterian Hospital, New York

10065

Weill Cornell - NYC, New York

17050

Pinnacle Health, Mechanicsburg

19104

Hospital of the University of Pennsylvania, Philadelphia

21201

University of Maryland, Baltimore, Baltimore

32608

University of Florida - Shands Hospital, Gainesville

44195

Cleveland Clinic Foundation, Cleveland

75093

The Heart Hospital of Baylor Plano, Plano

77030

Baylor College of Medicine - St. Luke's Hospital, Houston

90033

University of Southern California, Los Angeles

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY